Epigenetic Attenuation of Interferon Signaling is Associated With Aging-related Improvements in Systemic Lupus Erythematosus.
Supporting Files
-
June 2025
-
Available in CDC Stacks on March 24, 2026, 12:00 AM
File Language:
English
Details
-
Alternative Title:Science Translational Medicine, 2025, v. 17, no. 804: Epigenetic Attenuation of Interferon Signaling is Associated With Aging-related Improvements in Systemic Lupus Erythematosus.
-
Journal Article:Science Translational Medicine
-
Personal Author:Narendra, Rithwik ; Van Phan, Hoang ; Patterson, Sarah L. ; Almonte-Loya, Ana ; Lydon, Emily C. ; Lanata, Cristina ; Love, Christina ; Park, Joonsuk ; Shimoda, Michiko ; Barcellos, Lisa ; Mekonen, Honey ; Detweiler, Angela ; Deosthale, Padmini ; Neff, Norma ; Criswell, Lindsey A. ; Maliskova, Lenka ; Eckalbar, Walter ; Fragiadakis, Gabriela K. ; Yazdany, Jinoos ; Dall'Era, Maria ; Katz, Patricia ; Ye, Chun Jimmie ; Sirota, Marina ; Langelier, Charles R.
-
Description:In the general population, aging is associated with an increase in systemic inflammation and chronic disease burden. However, in systemic lupus erythematosus (SLE), older age is uniquely associated with a decrease in disease activity, suggesting a distinct relationship between aging and inflammation. Using a multiomic approach, we compared aging-related changes in the peripheral blood immune profiles of 287 patients with SLE and 928 healthy controls. In patients with SLE, aging correlated with lower expression of interferon (IFN)-stimulated genes (ISGs) across multiple cell types, decreased plasma IFN-α2, and differential genome methylation. Both patients with SLE and controls demonstrated age-related declines in naïve T cells, but only patients with SLE exhibited increases in CD56
natural killer cells with older age. Of the genes both down-regulated and hypermethylated with older age, ISGs were disproportionately represented, suggesting a role for epigenetic silencing. Altogether, we found that patients with SLE exhibit unique aging-related decreases in IFN signaling that correlate with improved disease activity. -
Content Notes:Author manuscript
-
Subjects:
-
Source:Science Translational Medicine, 2025, v. 17, no. 804
-
DOI:
-
ISSN:1946-6234 ; 1946-6242
-
Pubmed ID:40561001
-
Pubmed Central ID:PMC13012812
-
Document Type:
-
Funding:
-
Genre:
-
Pages in Document:eadt5550 (27 pdf pages)
-
Volume:17
-
Issue:804
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:b5735045d62a1416bcd3e419d0a50800b96e34612e628bbdca2d77021fc265b2e954ed58caf86c2dbcf9a8082fe9c9c4d870054249ad05a2bc53f138a06964bc
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access